St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

49.55USD
8:20pm IST
Change (% chg)

$-1.17 (-2.31%)
Prev Close
$50.72
Open
$49.73
Day's High
$50.05
Day's Low
$49.51
Volume
44,943
Avg. Vol
547,709
52-wk High
$80.35
52-wk Low
$49.31

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $14,336.53
Shares Outstanding(Mil.): 282.66
Dividend: 0.29
Yield (%): 2.29

Financials

Search Stocks

UPDATE 2-Medical device maker St. Jude 2016 forecast disappoints

* Q4 adj profit $1.02 vs est of $1.01 (Adds 2016 forecast, details)

27 Jan 2016

Medical device maker St. Jude reports lower quarterly profit

Jan 27 Medical device maker St. Jude Medical Inc's quarterly profit more than halved as sales in its cardiac rhythm management business continued to fall.

27 Jan 2016

St. Jude gets FDA warning letter for Atlanta facility

Heart device maker St. Jude Medical Inc received a warning letter from the U.S. Food and Drug Administration, which said that various devices of the company manufactured at its Atlanta plant are adulterated.

03 Oct 2015

UPDATE 1-St Jude gets FDA warning letter for Atlanta facility

Oct 2 Heart device maker St Jude Medical Inc received a warning letter from the U.S. Food and Drug Administration, which said that various devices of the company manufactured at its Atlanta plant are adulterated.

03 Oct 2015

St Jude Medical gets warning letter from FDA

Oct 2 Medical device maker St Jude Medical Inc said it had received a warning letter from the U.S. Food and Drug Administration related to "some non-conformities" observed from its manufacturing facility in Atlanta, Georgia.

03 Oct 2015

Fitch Downgrades St. Jude Medical; Rates Notes Offering 'A-'

(The following statement was released by the rating agency) CHICAGO, September 14 (Fitch) Fitch Ratings has downgraded St. Jude Medical, Inc.'s (STJ/St. Jude) long-term ratings to 'A-' from 'A', and its short-term rating to 'F2' from 'F1'. The ratings are removed from Negative Rating Watch, and assigned a Stable Outlook. See the full list of rating actions at the end of this release. Fitch has also assigned an 'A-' rating to the company's $1.5 billion notes offering, which will be used to p

14 Sep 2015

UPDATE 1-St. Jude Medical CEO Daniel Starks to retire in January

Sept 9 Medical device maker St. Jude Medical Inc said Chief Executive Daniel J. Starks would retire in January and Chief Operating Officer Michael T. Rousseau would replace him.

09 Sep 2015

St. Jude Medical CEO Daniel Starks to retire in January

Sept 9 Medical device maker St. Jude Medical Inc said Chief Executive Daniel J. Starks will retire in January and be replaced by Chief Operating Officer Michael T. Rousseau.

09 Sep 2015

Drugmaker Abbott says not pursuing an offer for St Jude Medical

Drugmaker Abbott Laboratories , knocking down a report in the Financial Times, denied on Thursday that it was preparing a bid for medical device maker St Jude Medical Inc .

27 Aug 2015

UPDATE 2-Drugmaker Abbott says not pursuing an offer for St Jude Medical

Aug 27 Drugmaker Abbott Laboratories told Reuters on Thursday it was not pursuing an offer to buy medical device maker St Jude Medical Inc.

27 Aug 2015

Earnings vs. Estimates

Search Stocks